Article Data

  • Views 1813
  • Dowloads 130

Original Research

Open Access

Clinical analysis of sentinel lymph node identification in patients with cervical cancer

  • Z. Zhang1,*,
  • Q. Chang1

1Department of Gynecology, Affiliated Hospital of Ningxia Medical University, Yinchuan (P.R China)

DOI: 10.12892/ejgo23502014 Vol.35,Issue 1,January 2014 pp.26-31

Published: 10 January 2014

*Corresponding Author(s): Z. Zhang E-mail: znqccn@163.com

Abstract

Objective: To study the accuracy and feasibility of identifying sentinel lymph nodes (SLN) using methylene blue dye in patients with cervical cancer. Materials and Methods: Fifty-six cases with early- stage cervical cancer patients were studied using methylene blue injection into the cervix 90~120 minutes before abdominal pelvic lymph node dissection and extensive hysterectomy. The lymph nodes that resulted from staining were removed and pathohistology was performed. Results: A total of 106 SLN were identified in 49 patients (49/56). The detection rate of SLN was 87.5%. Sensitivity of the SLN was 90.91%, and specificity of the sentinel lymph nodes was 86.67%. Eleven patients (19.64%) were diagnosed with lymph node metastases and ten of them were in the group of SLN. Eight patients had positive SLN only. Two patients had both positive SLN and pelvic lymph nodes. None of the patients had positive pelvic lymph nodes and negative SLN. Conclusion: The use of methylene blue injection for cervical cancer SLN biopsy has a higher detection rate of SLN. SLN detection can accurately predict the pathological status of pelvic lymph nodes in patients with cervical cancer.


Keywords

Endometrial cancer; Brachytherapy; Radiotherapy; Toxicity.


Cite and Share

Z. Zhang,Q. Chang. Clinical analysis of sentinel lymph node identification in patients with cervical cancer. European Journal of Gynaecological Oncology. 2014. 35(1);26-31.

References

[1] Lowy D.R., Schiller J.T.: “Prophylactic human papillomavirus vaccines”. J. Clin. Invest., 2006, 116, 1167.

[2] Cutts S., Franceschi S., Goldie S., Castellsague X., de Sanjose S., Garnett G., et al.: “Human papillomavirus and HPV vaccines: a review”. Bull. World Health Organ., 2007, 85, 719.

[3] Sakuragi N., Satoh C., Takeda N., Hareyama H., Takeda M., Yamamoto R., et al.: “Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages I B, II A and II B cervical carcinoma treated with radical hysterectomy”. Cancer, 1999, 85, 1547.

[4] Michel G., Morice P., Castaigne D.: “Lymphatic spread in stage I B and II A cervical carcinoma: anatomy and surgical implications”. Obstet. Gynecol., 1988, 91, 360.

[5] Magrina J.F., Goodrich M.A., Lidner T.K., Weaver A.L., Cornella J. L., Podratz K.C.: “Modified radical hysterectomy in the treatment of early squamous cervical cancer”. Gynecol. Oncol., 1999, 72, 183.

[6] Kowolik H.J., Kuhn W., Nahrig J., Werner M., Obst T., Avril N., et al.: “Detection of micrometastases in sentinel lymph node of breast applying monoclonal antibodies AE1/AE3 to pancytokeratins”. Oncol. Rep., 2000, 7, 745.

[7] Echt M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., Fiorica J.V.: “Detection of sentinel lymph nodes with lymphazurin in cervical, uterine and vulvar malignancies”. South. Med. J., 1999, 92, 204.

[8] Rob L., Charvat M., Robova H., Pluta M., Strnad P., Hrehorcak M., et al.: “Less radical fertility-sparing surgery than radical trachelectomy in early cervical cancer”. Int. J. Gynecol. Cancer, 2007, 17, 304.

[9] Ho C.M., Chien T.Y., Huang S.H., Wu C.J., Shih B.Y., Chang S.C.: “Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy”. Gynecol. Oncol., 2004, 93, 458.

[10] Levenback C., Coleman R.L., Burke T.W., Lin W.M., Erdman W., Deavers M.: “Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy”. J. Clin. Oncol., 2002, 20, 688.

[11] Buist M.R., Pijpers R.J., Van Lingen A., van Diest P.J., Dijkstra J., Kenemans P., et al.: “Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer”. Gynecol. Oncol., 2003, 90, 290.

[12] Plante M., Renaud M.C., Tetu B., Harel F., Roy M.: “Laparoscopic sentinel node mapping in early- stage cervical cancer”. Gynecol. Oncol., 2003, 91, 494.

[13] Angioli R., Palaia I., Cipriani C., Muzii L., Calcagno M., Gullotta G. ,et al.: “Role of sentinel lymph node biopsy procedure in cervical cancer:a critical point of view”. Gynecol. Oncol., 2005, 96, 504.

[14] Barranger E., Cortez A., Grahek D., Callard P., Uzan S., Darai E.: “Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer”. Ann. Surg. Oncol., 2004, 11, 344.

[15] Dargent D., Martin X., Mathevet P.: “Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer”. Gynecol. Oncol., 2000, 79, 411.

[16] Di Stefano A.B., Acquaviva G., Garozzo G., Barbic M., Cvjeticanin B., Meglic L., et al.: “Lymph node mapping and sentinel node de-tection in patients with cervical carcinoma: a-year experience”. Gynecol. Oncol., 2005, 99, 671.

[17] Vidal- Sicart S., Pons F., Puig S., Ortega M., Vilalta A., Martín F., et al.: “Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes”? Eur. J. Nucl. Med., 2003, 30, 362.

[18] Malur S., Krause N., Kohler C., Schneider A.: “Sentinel lymph node detection in patients with cervical cancer”. Gynecol. Oncol., 2001, 80, 254.

[19] Niikura H., Okamura C., Akahira J., Takano T., Ito K., Okamura K., et al.: “Sentinel lymph node detection in early cervical cancer with combination 99m Tc phytate and patent blue”. Gynecol. Oncol., 2004, 94, 528.

[20] Benedetti-Panici P., Maneschi F., Scambia G., Greggi S., Cutillo G., D'Andrea G., et al.: “Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy”. Gynecol. Oncol., 1996, 62, 19.

[21] Levenback C., Coleman R.L., Burke T.W., Lin W.M., Erdman W., Deavers M., et al.: “Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy”. J. Clin. Oncol., 2002, 20, 688.

[22] Kushner D.M., Connor J.P., Wilson M.A., Hafez G.R., Chappell R. J., Stewart S.L., et al.: “Laparoscopic sentinel lymph node mapping for cervix cancer-a detailed evaluation and time analysis”. Gynecol. Oncol., 2007, 106, 507.

[23] O’ Boyle D.J., Coleman R.L., Bernstein S.G., Lifshitz S., Muller C. Y., Miller D.S.: “Intraoperative Lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study”. Gynecol. Oncol., 2000, 79, 238.

[24] Darai E., Lavoue V., Rouzier R., Coutant C., Barranger E., Bats A.S.: “Contribution of the sentinel node procedure to tailoring the radicality of hysterectomy for cervical cancer”. Gynecol. Oncol., 2007, 106, 251.

[25] Coutant C., Morel O., Delpech Y., Uzan S., Daraï E., Barranger E.: “Laparoscopic sentinel node biopsy in cervical cancer using a comnined detection: 5-years experience”. Ann. Sung. Oncol., 2007, 14, 2392.


Abstracted / indexed in

Web of Science (WOS) (On Hold)

Journal Citation Reports/Science Edition

Google Scholar

JournalSeek

Submission Turnaround Time

Top